mRNA levels of two different enzymes in hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 57, Issue 102-103, 2010, Pages 1187-1190

  Wang, Yao Xian ^a   Meng, Xiang Wei ^c   Wang, Yin Dong ^b   Liu, Ying ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Heilongjiang Province Hospital   (China)

^c Basic Medical College   (China)

Author keywords

Hepatocellular carcinoma; mRNA expression

Indexed keywords

CYTOCHROME P450 2E1; GLUTATHIONE TRANSFERASE P1; MESSENGER RNA;

ARTICLE; CANCER RISK; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

AGED; CARCINOMA, HEPATOCELLULAR; CYTOCHROME P-450 CYP2E1; FEMALE; GLUTATHIONE S-TRANSFERASE PI; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RNA, MESSENGER;

EID: 79251564762     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Lewis DF, Ioannides C, Parke DV: Cytochromes P450 and species differences in xenobiotic metabolism and activation of carcinogen. Environ Health Perspect 1998; 106:633-641. PMID:9755138. (Pubitemid 29002676)
2. Boyer TD: The glutathione S-transferases: an update. Hepatology 1989; 9:486-496. PMID:2646197.
3. Nebert DW: Role of genetics and drug metabolism in human cancer risk. Mutat Res 1991; 247:267-281. PMID:2011144.
4. Standop J, Ulrich AB, Schneider MB, Buchler MW, Pour PM: Differences in the expression of xenobiotic-metabolizing enzymes between islets derived from the ventral and dorsal anlage of the pancreas. Pancreatology 2002; 2:510-518. PMID:12435863.
5. Guengerich FP, Shimada T: Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol 1991; 14:391-407. PMID:1912325.
6. Umeno M, McBride OW, Yang CS, Gelboin HV, Gonzalez FJ: Human ethanol-inducible P450IIE1: complete gene sequence, promoter characterization, chromosome mapping, and cDNA directed expression. Biochemistry 1988; 27:9006-9013. PMID:3233219.
7. Han XM, Zhou HH: Polymorphism of CYP450 and cancer susceptibility. Acta Pharmacol Sin 2000; 21:673-679. PMID:11501173.
8. Snawder JE, Lipscomb JC: Interindividual variance of cytochrome P450 forms in human hepatic microsomes: correlation of individual forms with xenobiotic metalolism and implications in risk assessment. Regul Toxical Pharmacol 2000; 32:200-209. PMID:11067776.
9. Stephens EA, Taylor JA, Kaplan N, Yang CH, Hsieh LL, Lucier GW, Bell DA: Ethnic variation in the CYP2E1 gene: polymorphism analysis of 695 African-Americans, European-Americans and Taiwanese. Pharmacogenetics 1994; 4:185-192. PMID:7987402.
10. Watanabe J, Hayashi S, Kawajiri K: Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5′-flanking region. J Biochem 1994; 116:321-326. PMID:7529759.
11. Hu Y, Hakkola J, Oscarson M, Ingelman-Sundberg M: Structural and functional characterization of the 5′-flanking region of the rat and human cytochrome P450 2E1 genes: identification of a polymorphic repeat in the human gene. Biochem Biophys Res Commun 1999; 263:286-293. PMID:10491286.
12. Hayashi S, Watanabe J, Kawajiri K: Genetic polymorphisms in the 5′-flanking region change transcriptional regulation o.f human cytochrome P450IIE1. J Biochem 1991; 110:559-565. PMID:1778977.
13. Board PG, Webb GC, Coggan M: Isolation of a cDNA clone and localization of the human glutathione S-transferase 3 genes to chromosome bands 11q13 and 12q13-14. Ann Hum Genet 1998; 53:205-213. PMID:2596826.
14. Harries LW, Stubbins M.J, Forman D, Howard GC, Wolf CR: Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 1997; 18:641-644. PMID:9111193.
15. Maher J: The CYP2E1 knockout delivers another punch: first ASH, now NASH. Alcoholic steatohepatitis. Non-alcoholic steatohepatitis. Hepatology 2001; 33:311-312. PMID:11124851.
16. Clot P, Albano E, Eliasson E, Tabone M, Arico S, Israel Y, et al: Cytochrome P4502E1 hydroxyethyl radical adducts as the major antigen in autoantibody formation among alcoholics. Gastroenterology 1996; 111:206-216. PMID:8698201.
17. Albano E, French SW, Ingelman-Sundberg M: Hydroxyethyl radicals in ethanol hepatotoxicity. Front Biosci 1999; 4:533-540. PMID:10369806.
18. Britton RS, Bacon BR: Role of free radicals in liver diseases and hepatic fibrosis. Hepatogastroenterology 1994; 41:343-348. PMID:7959569.
19. Ketterer B: A bird's eye view of the glutathione transferase field. Chem Biol Interact 2001; 138:27-42. PMID:11640913.
20. Sheehan D, Meade G, Foley VM, Dowd CA: Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem J 2001; 360:1-16. PMID:11695986.
21. Nelson HH, Wiencke JK, Christiani DC, Cheng TJ, Zuo ZF, Schwartz BS, et al: Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis 1995; 16:1243-1245. PMID:7767992.
22. Alves-Silva J, da Silva Santos M, Guimaraes PE, Ferreira AC, Bandelt HJ, Pena SD, et al: The ancestry of Brazilian mtDNA lineages. Am J Hum Genet 2000; 67:444-461. PMID:10873790.
23. Watson MA, Stewart RK, Smith GB, Massey TE, Bell DA: Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 1998; 19:275-280. PMID:9498276.
24. Setiawan VW, Zhang ZF, Yu GP, Lu QY, Li YL, Lu ML, et al: GSTP1 polymorphisms and gastric cancer in a high-risk Chinese population. Cancer Causes Control 2001; 12:673-681. PMID:11562107.
25. Fernandez-Checa JC, Hirano T, Tsukamoto H, Kaplowitz N: Mitochondrial glutathione depletion in alcoholic liver disease. Alcohol 1993; 10:469-475. PMID:8123202.